{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:15:02Z","timestamp":1788225302837,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-026-04430-0","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T11:47:52Z","timestamp":1781956072000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of target lesion restenosis after endovascular therapy for lower-extremity atherosclerotic peripheral artery disease: a real-world single center cohort"],"prefix":"10.1186","volume":"21","author":[{"given":"Hui","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"key":"4430_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2023.08.067","author":"J Nordanstig","year":"2023","unstructured":"Nordanstig J, Behrendt C-A, Baumgartner I, Belch J, B\u00e4ck M, Fitridge R, Hinchliffe R, Lejay A, Mills JL, Rother U, Sigvant B, Spanos K, Szeberin Z, van de Water W, Antoniou GA, Bj\u00f6rck M, Bastos Gon\u00e7alves F, Coscas R, Dias NV, McDermott MM. European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication. Eur J Vasc Endovasc Surg. 2023. https:\/\/doi.org\/10.1016\/j.ejvs.2023.08.067.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"24","key":"4430_CR2","doi-asserted-by":"publisher","first-page":"e1313","DOI":"10.1161\/CIR.0000000000001251","volume":"149","author":"HL Gornik","year":"2024","unstructured":"Gornik HL, Aronow HD, Goodney PP, Arya S, Brewster LP, Byrd L, et al. 2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. Circulation. 2024;149(24):e1313\u2013410. https:\/\/doi.org\/10.1161\/CIR.0000000000001251.","journal-title":"Circulation"},{"issue":"9","key":"4430_CR3","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","volume":"144","author":"MH Criqui","year":"2021","unstructured":"Criqui MH, Matsushita K, Aboyans V, Hess CN, Hicks CW, Kwan TW, McDermott MM, Misra S, Ujueta F, American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Lifestyle and Cardiometabolic Health. Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association. Circulation. 2021;144(9):e171\u201391. https:\/\/doi.org\/10.1161\/CIR.0000000000001005. Council on Peripheral Vascular Disease; and Stroke Council.","journal-title":"Circulation"},{"issue":"10","key":"4430_CR4","doi-asserted-by":"publisher","first-page":"e1553","DOI":"10.1016\/S2214-109X(23)00355-8","volume":"11","author":"GBD 2019 Peripheral Artery Disease Collaborators","year":"2023","unstructured":"GBD 2019 Peripheral Artery Disease Collaborators. Global burden of peripheral artery disease and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Global health. 2023;11(10):e1553\u201365. https:\/\/doi.org\/10.1016\/S2214-109X(23)00355-8.","journal-title":"Lancet Global health"},{"issue":"8","key":"4430_CR5","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3760\/CMA.J.ISSN.0529-5815.2016.08.002","volume":"54","author":"S Wang","year":"2016","unstructured":"Wang S, Yao C. Standardize the endovascular treatment for arteriosclerosis obliterans. Chin J Surg. 2016;54(8):564\u20137. https:\/\/doi.org\/10.3760\/CMA.J.ISSN.0529-5815.2016.08.002.","journal-title":"Chin J Surg"},{"issue":"9","key":"4430_CR6","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1161\/CIRCRESAHA.116.303503","volume":"116","author":"AK Thukkani","year":"2015","unstructured":"Thukkani AK, Kinlay S. Endovascular intervention for peripheral artery disease. Circul Res. 2015;116(9):1599\u2013613. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303503.","journal-title":"Circul Res"},{"issue":"4","key":"4430_CR7","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.21037\/JTD.2019.12.130","volume":"12","author":"DG Kokkinidis","year":"2020","unstructured":"Kokkinidis DG, Armstrong EJ. Current developments in endovascular therapy of peripheral vascular disease. J Thorac Disease. 2020;12(4):1681\u201394. https:\/\/doi.org\/10.21037\/JTD.2019.12.130.","journal-title":"J Thorac Disease"},{"issue":"18","key":"4430_CR8","doi-asserted-by":"publisher","first-page":"e1136","DOI":"10.4244\/eij-d-23-01080","volume":"20","author":"Y Gou\u00ebffic","year":"2024","unstructured":"Gou\u00ebffic Y, Brodmann M, Deloose K, Dubosq-Lebaz M, Nordanstig J. Drug-eluting devices for lower limb peripheral arterial disease. Eurointervention. 2024;20(18):e1136\u201353. https:\/\/doi.org\/10.4244\/eij-d-23-01080.","journal-title":"Eurointervention"},{"issue":"3","key":"4430_CR9","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1080\/00015458.2008.11680224","volume":"108","author":"E Minar","year":"2008","unstructured":"Minar E, Schillinger M. The evidence for stenting in femoropopliteal occlusive disease. Acta Chir Belg. 2008;108(3):292\u20137. https:\/\/doi.org\/10.1080\/00015458.2008.11680224.","journal-title":"Acta Chir Belg"},{"issue":"4","key":"4430_CR10","doi-asserted-by":"publisher","first-page":"386","DOI":"10.4244\/EIJV13I4A60","volume":"13","author":"R Nerla","year":"2017","unstructured":"Nerla R, Micari A, Cremonesi A. Drug-coated balloons and in-stent restenosis: a new tale of an old story. Eurointervention. 2017;13(4):386\u20137. https:\/\/doi.org\/10.4244\/EIJV13I4A60.","journal-title":"Eurointervention"},{"issue":"4","key":"4430_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1024\/0301-1526\/A000440","volume":"44","author":"NM Malyar","year":"2015","unstructured":"Malyar NM, Reinecke H, Freisinger E. Restenosis after endovascular revascularization in peripheral artery disease. Vasa-European J Vascular Med. 2015;44(4):257\u201370. https:\/\/doi.org\/10.1024\/0301-1526\/A000440.","journal-title":"Vasa-European J Vascular Med"},{"issue":"3","key":"4430_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/CCD.27238","volume":"91","author":"N Kobayashi","year":"2018","unstructured":"Kobayashi N, Hirano K, Yamawaki M, Araki M, Sakai T, Sakamoto Y, Mori S, Tsutsumi M, Honda Y, Tokuda T, Makino K, Shirai S, Ito Y. Characteristics and clinical outcomes of repeat endovascular therapy after infrapopliteal balloon angioplasty in patients with critical limb ischemia. Catheter Cardiovasc Interv. 2018;91(3):505\u201314. https:\/\/doi.org\/10.1002\/CCD.27238.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"22","key":"4430_CR13","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1016\/j.jcin.2016.08.036","volume":"9","author":"AC Salisbury","year":"2016","unstructured":"Salisbury AC, Li H, Vilain KR, Jaff MR, Schneider PA, Laird JR, Cohen DJ. Cost-Effectiveness of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons Versus Standard Percutaneous Transluminal Angioplasty: Results From the IN.PACT SFA II Trial. JACC Cardiovasc Intervent. 2016;9(22):2343\u201352. https:\/\/doi.org\/10.1016\/j.jcin.2016.08.036.","journal-title":"JACC Cardiovasc Intervent"},{"issue":"12","key":"4430_CR14","doi-asserted-by":"publisher","first-page":"e007559","DOI":"10.1161\/CIRCINTERVENTIONS.118.007559","volume":"11","author":"JA Rymer","year":"2018","unstructured":"Rymer JA, Jones WS. Femoropopliteal In-Stent Restenosis. Circ Cardiovasc Interv. 2018;11(12):e007559. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.118.007559.","journal-title":"Circ Cardiovasc Interv"},{"issue":"6","key":"4430_CR15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1177\/1708538120921005","volume":"28","author":"S Guo","year":"2020","unstructured":"Guo S, Zhang Z, Wang L, Yuan L, Bao J, Zhou J, Jing Z. Six-month results of stenting of the femoropopliteal artery and predictive value of interleukin-6: Comparison with high-sensitivity C-reactive protein. Vascular. 2020;28(6):715\u201321. https:\/\/doi.org\/10.1177\/1708538120921005.","journal-title":"Vascular"},{"issue":"7","key":"4430_CR16","doi-asserted-by":"publisher","first-page":"BSR20193448","DOI":"10.1042\/BSR20193448","volume":"40","author":"Y Yang","year":"2020","unstructured":"Yang Y, Ge F, Shen J, Song J, Xie J, Qu J, Mao X, Kuang Z, Wang X, Wu Y, Wang S, Xiao L. The relationship between neutrophil-lymphocyte ratio and in-stent restenosis in superficial femoral artery. Biosci Rep. 2020;40(7):BSR20193448. https:\/\/doi.org\/10.1042\/BSR20193448.","journal-title":"Biosci Rep"},{"issue":"3","key":"4430_CR17","doi-asserted-by":"publisher","first-page":"E225","DOI":"10.1532\/hsf.5303","volume":"26","author":"SY Tian","year":"2023","unstructured":"Tian SY. Systemic Immune-Inflammation Index Predicts Restenosis after Interventions for Lower Extremity Arteriosclerosis Obliterans. Heart Surg Forum. 2023;26(3):E225\u201333. https:\/\/doi.org\/10.1532\/hsf.5303.","journal-title":"Heart Surg Forum"},{"issue":"4","key":"4430_CR18","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1177\/17085381241251772","volume":"32","author":"E Oflar","year":"2024","unstructured":"Oflar E, Akdeniz E, Y\u0131ld\u0131z C, Koyuncu A, Mavi B, Karabulut D, \u00c7a\u011flar FNT, Kavala AA, T\u00fcrky\u0131lmaz S. Evaluation of systemic immune-inflammation index for predicting severity of lower extremity arterial disease. Vascular. 2024;32(4):797\u2013803. https:\/\/doi.org\/10.1177\/17085381241251772.","journal-title":"Vascular"},{"issue":"1S","key":"4430_CR19","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","volume":"58","author":"MS Conte","year":"2019","unstructured":"Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. European Journal of Vascular and Endovascular Surgery. 2019;58(1S):S1-S109.e33. https:\/\/doi.org\/10.1016\/j.ejvs.2019.05.006.","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"issue":"6","key":"4430_CR20","doi-asserted-by":"publisher","first-page":"E212","DOI":"10.1002\/ccd.25387","volume":"83","author":"KJ Rocha-Singh","year":"2014","unstructured":"Rocha-Singh KJ, Zeller T, Jaff MR, Peripheral Arterial Calcium Scoring System Working Group. Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv. 2014;83(6):E212\u201320. https:\/\/doi.org\/10.1002\/ccd.25387.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"21","key":"4430_CR21","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","volume":"66","author":"JR Laird","year":"2015","unstructured":"Laird JR, Schneider PA, Tepe G, Brodmann M, Zeller T, Metzger C, Krishnan P, Scheinert D, Micari A, Cohen DJ, Wang H, Hasenbank MS, Jaff MR, IN.PACT SFA Trial Investigators. Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA. J Am Coll Cardiol. 2015;66(21):2329\u201338. https:\/\/doi.org\/10.1016\/j.jacc.2015.09.063.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"4430_CR22","doi-asserted-by":"publisher","first-page":"E199","DOI":"10.1002\/ccd.24509","volume":"81","author":"O Kawarada","year":"2013","unstructured":"Kawarada O, Higashimori A, Noguchi M, Waratani N, Yoshida M, Fujihara M, Yokoi Y, Honda Y, Fitzgerald PJ. Duplex criteria for in-stent restenosis in the superficial femoral artery. Catheter Cardiovasc Interv. 2013;81(4):E199\u2013205. https:\/\/doi.org\/10.1002\/ccd.24509.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"Suppl S","key":"4430_CR23","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","volume":"45","author":"L Norgren","year":"2007","unstructured":"Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5\u201367. https:\/\/doi.org\/10.1016\/j.jvs.2006.12.037.","journal-title":"J Vasc Surg"},{"issue":"5","key":"4430_CR24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.arcmed.2019.08.009","volume":"50","author":"JC Fern\u00e1ndez-Mac\u00edas","year":"2019","unstructured":"Fern\u00e1ndez-Mac\u00edas JC, Ochoa-Mart\u00ednez AC, Varela-Silva JA, P\u00e9rez-Maldonado IN. Atherogenic Index of Plasma: Novel Predictive Biomarker for Cardiovascular Illnesses. Arch Med Res. 2019;50(5):285\u201394. https:\/\/doi.org\/10.1016\/j.arcmed.2019.08.009.","journal-title":"Arch Med Res"},{"issue":"5","key":"4430_CR25","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3906\/sag-2006-180","volume":"50","author":"B Duran Karaduman","year":"2020","unstructured":"Duran Karaduman B, Ayhan H, Kele\u015f T, Bozkurt E. The triglyceride-glucose index predicts peripheral artery disease complexity. Turk J Med Sci. 2020;50(5):1217\u201322. https:\/\/doi.org\/10.3906\/sag-2006-180.","journal-title":"Turk J Med Sci"},{"issue":"1","key":"4430_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41387-024-00341-y","volume":"14","author":"A Samavarchitehrani","year":"2024","unstructured":"Samavarchitehrani A, Cannavo A, Behnoush AH, Abadi K, Varniab AS, Z., Khalaji A. Investigating the association between the triglyceride-glucose index and peripheral artery disease: a systematic review and meta-analysis. Nutr diabetes. 2024;14(1):80. https:\/\/doi.org\/10.1038\/s41387-024-00341-y.","journal-title":"Nutr diabetes"},{"issue":"3","key":"4430_CR27","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jvs.2024.08.032","volume":"81","author":"CD Cerecedo","year":"2025","unstructured":"Cerecedo CD, Silva A, Alia VS, Vargas A, Garza A, El Shazly O, Candil AJ. Cilostazol after endovascular therapy for femoropopliteal peripheral arterial disease: A systematic review and meta-analysis. J Vasc Surg. 2025;81(3):767\u2013e7747. https:\/\/doi.org\/10.1016\/j.jvs.2024.08.032.","journal-title":"J Vasc Surg"},{"issue":"21","key":"4430_CR28","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","volume":"382","author":"MP Bonaca","year":"2020","unstructured":"Bonaca MP, Bauersachs RM, Anand SS, Debus ES, Nehler MR, Patel MR, et al. Rivaroxaban in peripheral artery disease after revascularization. New England Journal of Medicine. 2020;382(21):1994\u20132004. https:\/\/doi.org\/10.1056\/NEJMoa2000052.","journal-title":"New England Journal of Medicine"},{"key":"4430_CR29","doi-asserted-by":"publisher","unstructured":"Eikelboom, J. W., Connolly, S. J., Bosch, J., Dagenais, G. R., Hart, R. G., Shestakovska,O., Diaz, R., Alings, M., Lonn, E. M., Anand, S. S., Widimsky, P., Hori, M., Avezum,A., Piegas, L. S., Branch, K. R. H., Probstfield, J., Bhatt, D. L., Zhu, J., Liang,Y., Maggioni, A. P. COMPASS Investigators (2017). Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. The New England journal of medicine, 377(14), 1319\u20131330.https:\/\/doi.org\/10.1056\/NEJMoa1709118.","DOI":"10.1056\/NEJMoa1709118."}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-026-04430-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04430-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04430-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:45:42Z","timestamp":1788223542000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13019-026-04430-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4430"],"URL":"https:\/\/doi.org\/10.1186\/s13019-026-04430-0","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"7 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. The protocol was reviewed and approved by the Ethics Committee of the Affiliated Hospital of Southwest Medical University, which waived the requirement for informed consent because this was a retrospective analysis of de-identified routinely collected data and posed no more than minimal risk to participants. All data were anonymized prior to analysis.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"659"}}